A study of lung cancer among patients with beryllium (7440417) disease was conducted. The cohort consisted of 689 persons, 455 males, in the NIOSH Beryllium Case Registry (BCR). The BCR database included persons with documented evidence of beryllium exposure and clinically documented beryllium disease that was started by Massachusetts General Hospital in 1952 and taken over by NIOSH in the late 1970s. The vital status of the cohort was determined at the end of 1988. Death certificates were reviewed. Standardized mortality ratios (SMRs) were computed using rates for the United States (US) population as the reference. The smoking status of the cohort in 1965 was determined. A total of 428 deaths occurred in the cohort by the end of 1988. This yielded an SMR of 2.19. Twenty eight lung cancer deaths occurred, yielding an SMR of 2.00, a statistically significant increase. By sex, the lung cancer SMRs in females and males were 1.76 and 4.04, respectively. Both were statistically significant. Mortality from beryllium poisoning was significantly elevated, SMR 35.93. Pneumoconiosis mortality was significantly elevated, SMR 34.23. When categorized according to patients with acute or chronic beryllium disease, the lung cancer SMRs were 2.32 and 1.57, respectively. No other specific causes of death were significantly elevated. The cohort contained more former smokers and fewer current smokers than the general US population in 1965. Adjusting for smoking did not alter the lung cancer risk. The authors conclude that a two fold excess of lung cancer has been identified in male and female beryllium disease patients. The excess lung cancer mortality probably reflects exposure to beryllium, a suspected lung carcinogen. Beryllium disease itself could be a contributing factor to lung cancer.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.